Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$3.2M
+8.5% from 2023
Prescriptions
232
$13,677.75 per claim
Patients
46
54 prescribers
Total spending, 2024
$3.2M
$68,983.41 per patient
Medicare prescription drug plans paid $3.2M for Exjade in 2024, for 232 prescriptions and refills to 46 patients (up 8.5% from 2023). The average cost per claim was $13,677.75.
California had the highest Medicare cost for Exjade in 2024: $539K for 39 claims, followed by New York ($479K).
Michael Streiff, hematology-oncology in Baltimore, MD, had the highest Medicare cost for Exjade in 2024: 12 claims costing $284K.
Exjade is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Michael Streiff Baltimore, MD | Hematology-Oncology | 12 | Under 11 | $284K |
| Sean Tracy Rochester, MN | Internal Medicine | 11 | Under 11 | $271K |
| Derek W Holland |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 95 | 345 | 76 | $4.2M |
| 2023 | 67 | 232 | 55 | $2.9M |
| 2024 | 54 | 232 | 46 | $3.2M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 13 |
| Under 11 |
| $76K |
| Kerri Townsend Exeter, NH | Nurse Practitioner | 12 | Under 11 | $36K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 232 | $3.2M |